A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE

Clinical Investigation Training Program

Clinical Investigation Training Program
The Clinical Investigation Training Program (CITP) is committed to addressing the critical need for formal training and advancement in clinical research, as well as increasing the quantity, and more importantly, quality of well trained clinical investigators. The ultimate goal is to provide clinical research education, guided by apatient-centered philosophy, which will have a significant impact on cancer and other life-threatening diseases.
 
City of Hope's Clinical Investigation Training Program (CITP) is dedicated to a core group of objectives. Among these are:
  • Provide high-quality, multidisciplinary services to our scholars
     
  • Address the critical need for formal training and advancement in clinical investigation as well as increase the quantity and, more importantly, quality of well-trained clinical investigators.
     
  • Facilitate, through intensive mentoring, the transition fromscholar to independent clinical investigator
     
  • Bring City of Hope scientists and clinicians closer together to facilitate the bench-to-bedside continuum
     

CITP Core Curriculum

Core Curriculum
The City of Hope Clinical Investigation Training Program (CITP) is a yearlong (4 quarter) curriculum designed to present the principles and practices used in the planning and execution of patient-oriented research including principles and methods in biostatistics, clinical epidemiology, clinical trial development, ethics, and good clinical practices of research. Each course can be taken in any order throughout the year. A certificate in Clinical Research is awarded to scholars successfully completing the Program.
 
Methodology in Observational Studies CI510 (Fall) - Design & Analysis of Observational Research
Provides an overview of epidemiologic methods and their application to observational studies. Scholars will develop/enhance their ability to evaluate observational studies, including the adequacy of study design and the validity of stated conclusions. Scholars will also acquire the necessary conceptual frameworkto plan an observational study in collaboration with a statistical co-investigator.
 
Methodology in Therapeutic Studies CI520 (Winter) - Design& Analysis of Intervention Research
Provides anintroduction to the concepts, theory, and application of interventional clinical trials and the statistics commonly used to analyze these studies. This is a Biostatistics/Clinical Investiagation course that builds on basic background of biostatistics, and introductory clinical trials. This course will explore the fundamentals of clinical investigation including: the definition of study goals, application and theory, objectives and outcomes, trial design and outcome monitoring, and result reporting, as well as a brief review of the underlying statistical methods.
 
Study Design & Development CI530 (Spring) - Design & Development of Human Subject Research
Provides a review of the clinical study process as well as continued instruction in trial development. Scholars will experience the "Nuts and Bolts" of a clinical study, from submission, to committee review, activation, and monitoring. Each scholar will actively participate in the submission of a "mock" clinical protocol. The proper design, conduct, and analysis of a clinical study are imperative to the well being of each participant as well as the integrity of the study results. Responsible conduct of research and good clinical practice will be emphasized throughout the course as they are the cornerstones to an effective and efficient clinical study.
 
Scientific Writing & Evaluation CI550/1 (Summer)
This course will alternate yearly, and address topics in protocol writing and development (CI550) and career development awards (CI551). The emphasis of CI550 will be on developing a complete and feasible protocol leading to an efficient, effective clinical study. The classes will combine didactic instruction with small group discussions and "hands on" learning. The emphasis of CI551 will be on early career advancement, competitivegrant writing, and literature evaluation. This course will focus on developing a fundable, career development award suitable for peer review. Evaluations will be through oral presentations and a completed career development application.
 

Leadership

Faculty and Mentors

The Clinical Investigation Training Program’s faculty members are nationally-renowned scholars and researchers who are experts in teaching and conducting research. Our multidisciplinary faculty members hail from the world’s most prestigious universities and research institutions, and are the recipients of numerous awards and accolades.  City of Hope’s intimate and collegial environment allows faculty members to be effective mentors to program participants, leading them down the path to professional clinical researcher.
Education and Training
As one of only a select few National Cancer Institute-designated Comprehensive Cancer Centers in the country, City of Hope integrates all aspects of cancer research, treatment and education. We offer a range of programs serving students, post-doctoral trainees, health and medical professionals.

City of Hope’s Irell & Manella Graduate School of Biological Sciences equips students with the skills and strategies to transform the future of modern medicine.
City of Hope has a long-standing commitment to Continuing Medical Education (CME), sharing advances in cancer research and treatment with the health-care community through CME courses such as conferences, symposia and other on and off campus CME opportunities for medical professionals.
Local and national conferences, in-depth educational training and a certification program provide both current and aspiring health professionals opportunities to further their knowledge in their fields of interest.
 
 
City of Hope offers a range of programs and services, such as Graduate Medical Education & Clinical Training, that serve students, post-doctoral trainees, medical professionals and staff.
The goal of the Postdoctoral Training Office is to ensure the postdoctoral experience at City of Hope is rewarding and meaningful to all participants.
NEWS & UPDATES
  • Counter-intuitive though it might seem, a prostate cancer diagnosis shouldn’t always lead to immediate prostate cancer treatment. Although prostate cancer is the second-leading cancer killer of men, behind lung cancer, and causes more than 29,000 deaths in the U.S. each year, in many cases, the tumors are...
  • Radiology is one of the cornerstones of any hospital. It is a key diagnostic branch of medicine essential for the initial diagnosis of many diseases and has an important role in monitoring a patient’s treatment and predicting outcome. Radiology is the specialty considered to be both the “eyes” and “ears” of med...
  • Donating blood and platelets saves lives. We all know this. Yet every summer, potential blood donors become distracted by vacations and schedule changes. As a result, blood donations fall dramatically across the nation, leaving hospitals frantically trying to bring in much-needed blood for their patients. Earli...
  • To be a great cancer hospital, you need a great oncology program. Just ask City of Hope – and Becker’s Hospital Review. The health care publishing industry stalwart, described as the “leading hospital magazine for hospital business news and analysis for hospital and health system executives,” recently selected ...
  • Diagnostic errors are far from uncommon. In fact, a recent study found that they affect about 12 million people, or 1 in 20 patients,  in the U.S. each year. With cancer, those errors in diagnosis can have a profound impact. A missed or delayed diagnosis can make the disease that much harder to treat, as the Ag...
  • Eleven years ago, lymphoma patient Christine Pechera began the long road toward a cancer-free life. She had been diagnosed with non-Hodgkin lymphoma and told by doctors elsewhere that her lifespan likely would be measured in months, not years. Refusing to give up, she came to City of Hope for a second opinion. ...
  • Brain surgery is not for the faint of heart. It takes courage, as well as curiosity and compassion. The truly great surgeons also have a desire to find new, and better ways, of healing the brain. Enter Behnam Badie, M.D., chief of neurosurgery at City of Hope. Now a pioneer in brain tumor treatment, Badie enter...
  • Elizabeth Budde, M.D., Ph.D., wants to encourage infighting. She aims to turn the immune system on itself — to the benefit of patients with acute myeloid leukemia, or AML. AML arises when abnormal white blood cells grow out of control, amassing in the bone marrow and interfering with normal blood cell developme...
  • Six, to date; more soon. Outpatient bone marrow transplants, that is. Finding new ways to deliver quality care with the greatest benefit is a priority for a patient-centered institution like City of Hope. For example, not every bone marrow transplant patient needs to check into the hospital for treatment. In fa...
  • The best measure of success in the fight against cancer is in lives saved and families intact, in extra days made special simply because they exist. Yuman Fong, M.D., chair of the Department of Surgery at City of Hope, understands what precedes that special awareness. When cancer strikes, one minute a person ma...
  • In cancer, expertise matters. So do survival rates, patient safety, patient services and many other factors. City of Hope understands this, as does U.S.News & World Report. The magazine’s 2014-2015 list of best hospitals for cancer once again includes City of Hope, ranking the institution 12 out of 900 elig...
  • At 29, Kommah McDowell was a successful young professional engaged to be married to her best friend. She worked in the financial services sector and kick-boxed to keep in shape and to relax. Then came the diagnosis of triple-negative inflammatory breast cancer, a rare and very aggressive form of breast cancer. ...
  • The well-known drug tamoxifen might not always be the best choice for premenopausal women who have undergone treatment for breast cancer and face a heightened risk of recurrence. A new study suggests that the aromatase inhibitor exemestane, or Aromasin, works slightly better than tamoxifen in preventing cancer ...
  • At age 44, Bridget Hanchette, a mother of three from La Crosse, Wisconsin, was diagnosed with grade IV glioblastoma, the most aggressive type of malignant brain tumor. The cancer grows and spreads quickly, making it difficult to treat. Most patients with this diagnosis are not given much hope, but Hanchette’s i...
  • Survival rates for childhood cancer have improved tremendously over the past few decades, but postcancer care hasn’t always kept up. More children than ever are now coping with long-term complications and side effects caused by their disease and treatment — one of those being learning difficulties. A new ...